Illumina Shares Jump Amid Analyst Target Hikes
Illumina's stock surged 7.7% following price target increases from Wall Street analysts. The upgrades are attributed to expectations of improved clinical sales and new business catalysts.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.